The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2023

Filed:

Mar. 20, 2018
Applicant:

The Board of Trustees of the University of Illinois, Urbana, IL (US);

Inventors:

Brian T. Cunningham, Champaign, IL (US);

Rashid Bashir, Champaign, IL (US);

Anurup Ganguli, Urbana, IL (US);

Akid Ornob, Champaign, IL (US);

Gregory Damhorst, Elgin, IL (US);

Hojeong Yu, Savoy, IL (US);

Weili Chen, Sunnyvale, CA (US);

Fu Sun, Urbana, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01L 7/00 (2006.01); C12Q 1/6844 (2018.01); B01L 3/00 (2006.01); G01N 21/01 (2006.01); G01N 21/64 (2006.01);
U.S. Cl.
CPC ...
B01L 3/502715 (2013.01); B01L 7/52 (2013.01); C12Q 1/6844 (2013.01); G01N 21/01 (2013.01); G01N 21/6428 (2013.01); G01N 21/6452 (2013.01); G01N 21/6456 (2013.01); B01L 2200/10 (2013.01); B01L 2200/16 (2013.01); B01L 2300/06 (2013.01); B01L 2300/0809 (2013.01); B01L 2300/1805 (2013.01); B01L 2400/0487 (2013.01); B01L 2400/06 (2013.01); G01N 2021/6439 (2013.01); G01N 2021/6471 (2013.01);
Abstract

A sample carrier may include a sample preparation module and an amplification module. A sample mixes with a lysis medium and a nucleic acid amplification medium in the sample preparation module and then flows into a plurality of microfluidic chambers in the amplification module. The microfluidic chambers have disposed therein primers configured to initiate amplification of one or more target nucleic acid sequences corresponding to one or more pathogens. The sample carrier is inserted into an apparatus that includes a plurality of Sight sources and a camera. The light sources illuminate the microfluidic chambers with excitation light, a fluorophore emits fluorescence light indicative of nucleic acid amplification in response to the excitation-light, and the camera captures images of the microfluidic chambers. A target nucleic acid sequence in the sample is indicated by the images showing an increasing fluorescence in a microfluidic chamber that has the primers for that sequence.


Find Patent Forward Citations

Loading…